Skip to main content
WHTCF logo

WELL Health Technologies Corp. (WHTCF) Stock Price & Analysis

WELL Health Technologies Corp. (WHTCF) — price $2.57 (+1.98%), as of the Nov 19, 2026 trading session; market cap $660M.

Educational signal · not a buy or sell recommendation · How to read this

$2.57 +$0.05 (+1.98%) Market Cap $660M

WELL Health Technologies Corp. · WHTCF

WELL Health Technologies Corp. is a Canadian-based digital health company operating in Canada, the United States, and internationally. They provide end-to-end omni-channel patient services and digital health solutions, including telehealth platforms and electronic medical records systems.

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • PIII · P3 Health Partners Inc. · 31 /100
  • PNTG · The Pennant Group, Inc. · 68 /100
  • INNV · InnovAge Holding Corp. · 92 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$2.57
Change on the day+1.98%
52-week range$2.44 – $3.71
Market capitalisation$660M—
Price / earnings (trailing)167.98
Shares traded on the day100

Price & events

Other perspectives

Council score for WELL Health Technologies (WHTCF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Nov 13, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Debt/Equity Weak
ROE Weak
Gross Margin Moderate

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is WELL Health Technologies (WHTCF), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. WELL Health Technologies Corp. (WHTCF) is the company analyzed here. It employs 1,507 people and is led by Hamed Shahbazi. In Q2 FY2026 it reported revenue of C$400M and net income of -C$11M. The market values it at $660M.

2 · Latest results

What do the latest results show for WELL Health Technologies (WHTCF)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of C$400M. Against analyst estimates the company has EPS beat 5 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026C$400M-C$11M-C$0.04 (diluted)
Q1 FY2026C$369M-C$12M-C$0.05 (diluted)
Q4 FY2025C$384MC$23MC$0.10 (diluted)
Q3 FY2025C$365MC$4MC$0.02 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for WELL Health Technologies (WHTCF)?

Short answer · as of

The distress and quality screens read Altman Z 1.11 · Piotroski F 5. Trailing ratios: ROE 0.4% · ROA 0.2% · current ratio 0.80 · earnings yield 0.3% · free-cash-flow yield 7.8%.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held WHTCF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported WHTCF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about WELL Health Technologies (WHTCF)?

Read these with our analysis →

Common Questions About WHTCF

These answers are editorial: 2 of these 8 answers are drawn from the WHTCF research dossier (written Mar 15, 2026 by gemini-2.0-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is WHTCF a good stock to buy?

Stock Expert AI does not rate WHTCF buy, sell or hold. WELL Health Technologies Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the WHTCF stock price today?

The last price recorded for WELL Health Technologies Corp. (WHTCF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What do analysts say about WHTCF stock?

Generally, analysts will assess WELL Health Technologies Corp. based on its growth prospects in the digital health market, adoption rates of its OSCAR Pro EMR platform, and the success of its telehealth services. Key valuation metrics include revenue growth, gross margin, and profitability.

What are the main risks for WHTCF?

WELL Health Technologies Corp. faces several risks inherent in the digital health industry. Intense competition from established players and new entrants could erode market share.

What are the key factors to evaluate for WHTCF?

Evaluate WHTCF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Expansion into the US Market: WELL Health has the opportunity to expand its presence in the US market, which is the largest healthcare market in the world. Not financial advice.

How frequently does WHTCF data refresh on this page?

WHTCF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven WHTCF's recent stock price performance?

WELL Health Technologies Corp. (WHTCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of digital health solutions. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider WHTCF overvalued or undervalued right now?

The trailing P/E of WELL Health Technologies Corp. (WHTCF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 15 figures on this page — 8 from Financial Modeling Prep (FMP) and 7 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.